ArticleChemistry & biodiversity2026
Osteoprotective Effects and In Silico Profiling of Parinari curatellifolia Planch. Ex Benth. (Chrysobalanaceae) Extract on Acute Plasmodium berghei-Compromised Rat Bone.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Parinari curatellifolia leaves and stem bark are traditionally used, to treat both malaria and bone disorders. This work aimed at investigating the osteoformative effects of the P. curatellifolia aqueous leaves and bark mixture extract on malaria-induced bone alterations. The in vitro antiplasmodial activity of the extract was assessed on Plasmodium falciparum 3D7 and Dd2. The phytochemical characterization of the extract and its fractions was carried out using LC-MS technique. The in vivo study was evaluated using Plasmodium berghei ANKA-induced malaria and bone disorders. Parasitemia was monitored, and hematological, biochemical, immunological, and histopathological parameters were assessed. The docking study was performed on Pf20S, TyrRS, MyD88, and RANKL using the Molecular Operating Environment 14. The extract exhibited in vitro antiplasmodial activity on P. falciparum 3D7 and Dd2 strains. The LC-MS analysis of the extract and fractions revealed several peaks, of which 12 were characterized. The extract reduced parasitemia (p < 0.001), improved hematological parameters, corrected malaria-induced bone damage by increasing (p < 0.001) bone osteocalcin, TGF-β1, ALP activity, mineralization, as well as reversing Plasmodium-induced inflammation. Likewise, the identified compounds exhibited strong inhibitory binding potential. These findings support the ability of the extract to correct malaria-related bone disorders by acting as an antiplasmodial, osteoprotective, anti-inflammatory, and antioxidant agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.